Vaccination site lymphadenopathy and Gallbladder cancer recurrent - from FDA reports
There is no Gallbladder Cancer Recurrent reported by people with Vaccination Site Lymphadenopathy yet. We study people who have Gallbladder Cancer Recurrent and Vaccination Site Lymphadenopathy from FDA . Find out below who they are, other conditions they have and drugs they take.
What to expect?
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Aug, 17, 2017
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Gallbladder cancer recurrent and Vaccination site lymphadenopathy?
Expand the study to include reports from both FDA and eHealthMeGallbladder cancer recurrent and Vaccination site lymphadenopathy from FDA and eHealthMe reports
Vaccination Site Lymphadenopathy
Vaccination site lymphadenopathy (abnormal enlargement of the lymph nodes- vaccination site) (latest reports from 1 Vaccination site lymphadenopathy patients)
Gallbladder Cancer Recurrent
Gallbladder cancer recurrent (repeat cancer of gallbladder) has been reported by people with emphysema, hyperuricaemia, gallbladder cancer, rheumatoid arthritis, diabetes (latest reports from 24 Gallbladder cancer recurrent patients).